Lucivos is used in the treatment of acute myeloid leukemia
(AML) with IDH1 mutation. It is a targeted therapy designed to improve outcomes
in specific genetic cancer types.
Active Ingredient
Ivosidenib inhibits mutated IDH1 enzyme, restoring normal
cell differentiation.
Uses of Lucivos
• Acute myeloid leukemia (IDH1 mutation)
How Lucivos Works
It blocks abnormal IDH1 enzyme activity, helping immature
blood cells mature normally.
How to Use Lucivos
• Take once daily
• Follow doctor’s instructions
Possible Side Effects
• Fatigue
• Diarrhea
• Joint pain
Precautions
• Monitor heart rhythm
• Regular blood tests required
Safety Information
Use under strict medical supervision.
Storage
• Protect from moisture and sunlight
• Keep out of reach of children